Molecular cues support that the unique characteristics of the clonotypic B cell receptor immunoglobulin (BcR IG) strongly affect the intensity of downstream intracellular signaling cascades in CLL cells, regulating their proliferation and survival, and, eventually, also impacting on the clinical course. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.